Mangoceuticals Inc (MGRX) Stock Price, Quote & News

Company Profile

Mangoceuticals, Inc. engages in the development, marketing, and sale of various men's wellness products and services through a telemedicine platform in the United States. The company offers erectile dysfunction products under the Mango brand; hair loss products under the Grow brand; hormone balance and therapy products under the Mojo brand; and weight loss products under the Slim brand. It also provides oral testosterone undecanoate to treat low testosterone in men and as a form of testosterone...

Industry: Health Information Services

Sector: Healthcare

Phone: 214 242 9619

Website: www.mangoceuticals.com

Address:

15110 N. Dallas Parkway, Suite 600, Dallas, United States

KryptonianTrader Nov. 15 at 1:11 AM

$MGRX THE PHUCK LYING PROPAGANDA YOU SELLING?? GO BACK TO GROOMING YOUR OLD LADY.. SHORT LOSER…😂😂😂😂

1 · Reply

bilocelhi Nov. 15 at 12:41 AM

$MGRX 10Q released. Offering coming shortly, possibly as soon as Monday.

0 · Reply

only1mc Nov. 14 at 11:51 PM

$MGRX made money here today $AKAN took a small L . i will have its day

0 · Reply

d_risk Nov. 14 at 11:12 PM

$MGRX - MANGOCEUTICALS, INC. - 10Q - Updated Risk Factors MGRX flags new risks tied to the ongoing government shutdown, potentially impacting operations and regulatory processes. #Pharmaceuticals #OperationalRisk #RegulatoryRisk #GovernmentShutdown 🟢 Added 🟠 Removed https://d-risk.ai/MGRX/10-Q/2025-11-14

1 · Reply

BullishBee Nov. 14 at 9:48 PM

It's not just the AI Bot. 🤖 Our Momentum Bot is putting in serious work today. This is the power of our full bot suite. Today's Momentum Bot Hits: $NUAI: +7.5% TP1 HIT ✅ $MGRX: +7.5% TP1 HIT ✅ $LGN: +7.5% TP1 HIT ✅ The system's job is to find the signal and hit the target. 🎯 We're beta testing the full suite. Follow & DM for access! 💪🐝

0 · Reply

BullishBee Nov. 14 at 8:58 PM

The AI Bot is just checking off a list today. 🎯 It's 4 more setups setups and smashed the +10% profit target. Today's AI Hit List: $CYPH: +10.0% TP1 HIT ✅ $IONX.X: +10.0% TP1 HIT ✅ $GAUZ: +10.0% TP1 HIT ✅ $MGRX: +10.0% TP1 HIT ✅ The system's job is to find the signal and hit the target. It's doing its job flawlessly. We're beta testing this bot right now. Follow & DM for access! 💪🐝

0 · Reply

uratwitx2 Nov. 14 at 8:57 PM

$MGRX It's a start - I'm up $17K on the day, still in the hole $49K. Maybe after hours this will move?

1 · Reply

2jmoney Nov. 14 at 8:53 PM

$MGRX my man @BeachbumInvestor this recovery is for you 💪

0 · Reply

Outsiderin Nov. 14 at 8:33 PM

$MGRX dont sell for pennies i will go atleast 2$ for sure

0 · Reply

Nikolinit Nov. 14 at 8:13 PM

$MGRX bullish shorts will pay for yesterday

0 · Reply

Mangoceuticals Provides Clarification on Launch of Branded GLP-1 Weight-Management Programs

Nov 13, 2025, 2:04 PM EST - 1 day ago

Novo Nordisk, Lilly deny partnership with Mangoceuticals on obesity drugs

LLY NVO

Nov 13, 2025, 7:15 AM EST - 1 day ago

Mangoceuticals partners with Lilly, Novo Nordisk to sell weight-loss drugs

LLY NVO

May 27, 2025, 9:00 AM EDT - 6 months ago

Mangoceuticals' Patented MGX-0024 Delivers 100% Respiratory Survival in Poultry Studies Signaling Strong Potential Defense Against Spread of Avian Flu

Apr 28, 2025, 9:36 AM EDT - 7 months ago

ArcStone Securities and Investments Corp. Publishes Industry Report on The Rapid Expansion of The Oral Stimulant Pouch Market

Apr 26, 2025, 10:54 AM EDT - 7 months ago

CORRECTION FROM SOURCE: ArcStone Securities and Investments Corp. Serves as Exclusive Financial Advisor to Mangoceuticals Inc. (MGRX) on its Transformative Acquisition of IP Assets of Smokeless Technology Corp. Marking its Entry into the High Growth Oral Stimulant Pouch Sector

Apr 25, 2025, 10:26 AM EDT - 7 months ago

ArcStone Securities and Investments Corp. Serves as Exclusive Financial Advisor to Mangoceuticals Inc. (MGRX) on its Transformative Acquisition of Smokeless Technology Corp. Marking its Entry into the High Growth Oral Stimulant Pouch Sector

Apr 25, 2025, 9:00 AM EDT - 7 months ago

Mangoceuticals Announces Strategic Entry into High Growth Pouch Industry Through Acquisition of Smokeless Technology IP and Appointment of Tim Corkum Ex Philip Morris Executive to Lead High Growth Pouch Division

Apr 22, 2025, 1:55 PM EDT - 7 months ago

CEO Spotlight: How Mangoceuticals Inc. is Reinventing The Personal Health Landscape

Feb 3, 2025, 8:30 AM EST - 10 months ago

Mangoceuticals, Inc. Executes Exclusive Distribution Agreement with Propre Energie for Clinically Proven Dermytol®️ Skincare Treatment Targeting Hyperpigmentation

Dec 19, 2024, 5:33 PM EST - 11 months ago

Mangoceuticals, Inc. Completes Acquisition of Mushroom-Based Wellness and Innovations Patent

Oct 21, 2024, 5:10 PM EDT - 1 year ago

MangoRx Responds to and Refutes Recent Claims Made by Eli Lilly

Oct 18, 2024, 8:45 AM EDT - 1 year ago

Mangoceuticals, Inc. Announces Participation at the Centurion One Capital 2nd Annual Bahamas Summit 2024

Oct 11, 2024, 5:15 PM EDT - 1 year ago

MANGOCEUTICALS, INC. ANNOUNCES 1-FOR 15 REVERSE STOCK SPLIT AS PART OF NASDAQ COMPLIANCE PLAN

Oct 3, 2024, 8:30 AM EDT - 1 year ago

MangoRx Introduces Oral Tirzepatide GLP-1 Receptor Agonist for Advanced Weight Loss Solutions

Oct 1, 2024, 7:30 AM EDT - 1 year ago

MangoRx Addresses $49.3 Billion Global GLP-1 Market With Launch of Oral Semaglutide for Advanced Weight Loss Treatment

Aug 15, 2024, 9:25 AM EDT - 1 year ago

MangoRx Reports 1,685% Increase in Shareholders' Equity From December 31, 2023, to $13.8MM, and 56% Increase in Year-Over-Year Revenue for First Half of 2024

Aug 9, 2024, 8:15 AM EDT - 1 year ago

MangoRx Completes Migration to DEA-Approved Telemedicine Platform, Accelerating Timeline of Oral Dissolvable GLP-1 Weight Loss Treatments Featuring Semaglutide and Tirzepatide

Aug 8, 2024, 8:30 AM EDT - 1 year ago

MangoRx Receives Request for Proposal (RFP) From ISFLST for New Male Enhancement Product Exclusive for the Asian Market

Jul 24, 2024, 8:15 AM EDT - 1 year ago

MangoRx Initiates Efficacy Studies on its Patented Respiratory Illness Prevention Technology

Jul 18, 2024, 4:05 PM EDT - 1 year ago

Mangoceuticals CEO Jacob Cohen Featured on Benzinga All-Access

Jul 16, 2024, 8:20 AM EDT - 1 year ago

MangoRx Secures DEA Approval for Proprietary HIPAA-Compliant Operating System via Surescripts

Jul 12, 2024, 1:30 PM EDT - 1 year ago

MangoRx Appoints Dr. Douglas Christianson, N.D. as Director of the Medical Research and Product Innovation Department

Jul 11, 2024, 8:15 AM EDT - 1 year ago

MangoRx Announces Strategic Partnership for Expansion into Asia Pacific and Key Emerging Markets

Jun 6, 2024, 8:30 AM EDT - 1 year ago

MangoRx Receives Notice of Acceptance for Patent Application in Australia for Respiratory Illness and Preventive Care Technology

Jun 4, 2024, 4:00 PM EDT - 1 year ago

MangoRx Receives Patent Notice of Allowance in Japan for Revolutionary Preventive Care Technology Acquired from Intramont Technologies

May 28, 2024, 8:30 AM EDT - 1 year ago

Mangoceuticals, Inc. Announces Completion of First Batch of Mango ED Products for Marketing and Distribution in Mexico and Latin American Markets

May 23, 2024, 8:30 AM EDT - 1 year ago

MangoRx Engages Renown International Digital and Performance Marketing Company Crakmedia to Champion its Digital Marketing Efforts

May 21, 2024, 8:30 AM EDT - 1 year ago

MangoRx to Introduce Oral Semaglutide and Tirzepatide in Response to Increasing Patient Demand for GLP-1 Medications

May 16, 2024, 4:40 PM EDT - 1 year ago

MangoRx Reports Revenue Growth of 108% in Q1 2024 Fueled by Amplified Customer Acquisition and Early Market Penetration

May 2, 2024, 8:00 AM EDT - 1 year ago

Mangoceuticals Granted 180-Day Extension to Meet Nasdaq Minimum Bid Price Requirement and Conditional Approval of Compliance with Nasdaq's Minimum Stockholders' Equity Requirement

Apr 12, 2024, 8:45 AM EDT - 1 year ago

Mangoceuticals Subsidiary, MangoRx Mexico, Executes Technical Agreement with Mexican Pharmaceutical Manufacturer for Initial Development and Production of its Mango Erectile Dysfunction (ED) Products

Mar 12, 2024, 9:00 AM EDT - 1 year ago

MangoRx Officially Launches ‘PRIME' by MangoRx, Powered by Kyzatrex®️ FDA Approved Oral Testosterone Replacement Therapy (TRT) Treatment

Feb 20, 2024, 9:00 AM EST - 1 year ago

MangoRx Launches Direct-To-Clinics Sales Division to Drive and Fuel Customer Acquisition and Revenue Growth

Feb 6, 2024, 9:00 AM EST - 1 year ago

MANGORX TO OFFER THE BIG GAME'S LOSING TEAM A FREE ONE YEAR SUPPLY OF ITS ED PRODUCT, MANGO, TO HELP RAISE

Feb 5, 2024, 8:50 AM EST - 1 year ago

MangoRx Accepting Pre Orders for its “PRIME”, by MangoRx, Powered by Kyzatrex®️ FDA Approved Oral Testosterone Replacement Therapy (TRT) Product

Jan 19, 2024, 8:00 AM EST - 1 year ago

MangoRx's Brand and Products to be Featured by Barstool Sports in Week of Programming Around the Biggest Sports Event of the Year on February 11

Dec 15, 2023, 10:39 AM EST - 2 years ago

Mangoceuticals, Inc. Announces Pricing of $1,200,000 Public Offering

Dec 13, 2023, 7:30 AM EST - 2 years ago

MANGOCEUTICALS TO INTRODUCE “PRIME”, POWERED BY KYZATREX®️ (CIII TESTOSTERONE UNDECANOATE CAPSULES), FOR AN FDA APPROVED ORAL TESTOSTERONE REPLACEMENT THERAPY (TRT) PRODUCT

Dec 6, 2023, 8:00 AM EST - 2 years ago

Mangoceuticals Launches MangoRx Mexico Subsidiary, Paving the Way for Over-the-Counter Retail of Erectile Dysfunction Line of Products in Latin America

Nov 29, 2023, 8:30 AM EST - 2 years ago

Mangoceuticals Selects TRYBE Labs as its Nationwide Blood Collection and Testing Services Provider

Nov 16, 2023, 8:30 AM EST - 2 years ago

Mangoceuticals Expands its Men's Health Product Line with Compounded Hair Growth Treatment 'Grow' by MangoRx

Nov 2, 2023, 9:15 AM EDT - 2 years ago

Mangoceuticals, Inc. Launches Charitable Initiative in Support of Men's Health Awareness Month

Oct 26, 2023, 7:30 AM EDT - 2 years ago

Mangoceuticals Launches TikTok Influencer Initiative and Becomes the Presenting Sponsor of the Only Stans Podcast with Glenny Balls

Oct 13, 2023, 9:40 AM EDT - 2 years ago

Mangoceuticals Announces TV Air Dates for Interview Featuring CEO Jacob Cohen on Bloomberg TV and Fox Business

Oct 12, 2023, 9:15 AM EDT - 2 years ago

Mangoceuticals Announces the Official Launch of MangoRx Affiliate Marketing Program to Enhance and Accelerate Topline Growth

Aug 30, 2023, 8:00 AM EDT - 2 years ago

Mangoceuticals Launches New High-Production Quality Ad Providing Fresh Insight into its Proprietary Mango Erectile Dysfunction Pill Formula

Aug 16, 2023, 8:00 AM EDT - 2 years ago

Mangoceuticals Launches New Sildenafil Based Erectile Dysfunction Product with Signature Mango Flavor & Rapid Dissolve

Jul 18, 2023, 10:00 AM EDT - 2 years ago

Mangoceuticals Engaged by Social Media Sensation Adam22 as Exclusive New Sponsor of Hit Podcasts with Skyrocketing Male Engagement

Jun 29, 2023, 10:00 AM EDT - 2 years ago

Mangoceuticals Collaborates with Ice Shaker to Launch Mango Branded Ice Shaker Protein Bottles on MakeAmericaHardAgain.com

KryptonianTrader Nov. 15 at 1:11 AM

$MGRX THE PHUCK LYING PROPAGANDA YOU SELLING?? GO BACK TO GROOMING YOUR OLD LADY.. SHORT LOSER…😂😂😂😂

1 · Reply

bilocelhi Nov. 15 at 12:41 AM

$MGRX 10Q released. Offering coming shortly, possibly as soon as Monday.

0 · Reply

only1mc Nov. 14 at 11:51 PM

$MGRX made money here today $AKAN took a small L . i will have its day

0 · Reply

d_risk Nov. 14 at 11:12 PM

1 · Reply

BullishBee Nov. 14 at 9:48 PM

0 · Reply

BullishBee Nov. 14 at 8:58 PM

0 · Reply

uratwitx2 Nov. 14 at 8:57 PM

$MGRX It's a start - I'm up $17K on the day, still in the hole $49K. Maybe after hours this will move?

1 · Reply

2jmoney Nov. 14 at 8:53 PM

$MGRX my man @BeachbumInvestor this recovery is for you 💪

0 · Reply

Outsiderin Nov. 14 at 8:33 PM

$MGRX dont sell for pennies i will go atleast 2$ for sure

0 · Reply

Nikolinit Nov. 14 at 8:13 PM

$MGRX bullish shorts will pay for yesterday

0 · Reply

Donniechen12345 Nov. 14 at 8:02 PM

$MGRX sold all 42k shares . thx all trade safe lol 1.46 , 1.48 lol lmao gooodluck !!!!!! moving on:)))))))

1 · Reply

DonDon531 Nov. 14 at 8:00 PM

$MGRX doing rather nicely I must say🤑

0 · Reply

BigALB Nov. 14 at 8:00 PM

$MGRX once the price breaks over 1.53, the book is very thin, just letting anyone here that doesn’t use bookmap now. GLTA

0 · Reply

SkyLonger Nov. 14 at 7:49 PM

$MGRX lets see the company buy back over 2 make people whole again !

1 · Reply

king9885 Nov. 14 at 7:29 PM

$MGRX this will raise to $2

0 · Reply

Outsiderin Nov. 14 at 6:51 PM

$MGRX if it hold may be ???

0 · Reply

BigALB Nov. 14 at 6:37 PM

$MGRX Still here and waiting, picked up an extra 10k this morning on the dip into the .90’s as I had already planned, so now it’s 75k at 1.70 for sale, small lots 2.5K each, to keep the L2 light. GLTA

1 · Reply

SkyLonger Nov. 14 at 6:27 PM

$MGRX nobody knows where this will end up ....however its heading in the right direction after yesterday ...doesn't make anything right after though

0 · Reply

Donniechen12345 Nov. 14 at 5:06 PM

$MGRX someone or some covered and went long . lmao 200k blocks shares lmao good job smart hehe $$$$&

1 · Reply

Donniechen12345 Nov. 14 at 5:02 PM

$MGRX someone just covered and went long on that big green candle hahaha smart :)))))

0 · Reply

bilocelhi Nov. 14 at 4:59 PM

$MGRX what else would you expect from a company named Mango, but to lie lol

0 · Reply

bilocelhi Nov. 14 at 4:46 PM

$MGRX crap is about to tank AH

1 · Reply

Market Cap	12.54M
Revenue (ttm)	620,000.00
Net Income (ttm)	-8.71M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-1,404.84%
Debt to Equity Ratio	0.00

Volume	3,813,300
Avg Vol	1,677,084
Day's Range	N/A - N/A
Shares Out	10.54M
Stochastic %K	35%
Beta	2.39
Analysts	Strong Buy
Price Target	N/A